Michael S. Hadley

1.8k citations

55 papers · 1.0k indexed · h-index 16

Organic Chemistry top 5%
- Asymmetric Synthesis and Catalysis 7
- Synthesis of heterocyclic compounds 7
- Cyclopropane Reaction Mechanisms 5
- Synthesis and Reactivity of Heterocycles 4
Endocrine and Autonomic Systems top 5%
Cellular and Molecular Neuroscience top 5%
- Neuroscience and Neuropharmacology Research 6
Molecular Biology
- Receptor Mechanisms and Signaling 13
- Pharmacological Receptor Mechanisms and Effects 7
- Phenothiazines and Benzothiazines Synthesis and Activities 5
Experimental and Cognitive Psychology top 10%

Co-authors: Graham J. Riley Geoffrey Stemp Michael Clark Barry S. Orlek John Evans Frank D. King Frank Brown Paul Wyman
Cited by: Organic Chemistry Endocrine and Autonomic Systems Cellular and Molecular Neuroscience
Journals: Journal of Medicinal Chemistry (11 papers)Psychopharmacology (1 paper)Tetrahedron Letters (2 papers)
Partner nations: United Kingdom United States

In The Last Decade

Michael S. Hadley

52 papers receiving 949 citations

Peers

Countries citing papers authored by Michael S. Hadley

Since Specialization

Citations

This map shows the geographic impact of Michael S. Hadley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Hadley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Hadley more than expected).

Fields of papers citing papers by Michael S. Hadley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Hadley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Hadley. The network helps show where Michael S. Hadley may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael S. Hadley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael S. Hadley Line = papers co-authored together Michael S. Hadley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cardiac Magnetic Resonance for Structural Aortic Valve Stenosis Procedures Journal of Clinical Medicine ·Marcos Ferrández-Escarabajal,Michael S. Hadley,Javier Sanz	2024	1
2	PO-06-197 VENTRICULAR TACHYCARDIA ABLATION IN A PATIENT WITH LEFT VENTRICULAR PSEUDOANEURYSM USING PULSED FIELD ABLATION Heart Rhythm ·Abhishek Maan,Daniel R. Musikantow,Michael S. Hadley,Kelly Jia,Iwanari Kawamura,Mohit K. Turagam,Srinivas R. Dukkipati,Vivek Y. Reddy	2024	0
3	‘Is it the same patient?’ Evidence of significant cardiac amyloid regression European Heart Journal - Cardiovascular Imaging ·Solomon Bienstock,Marcos Ferrández-Escarabajal,Michael S. Hadley,Javier Sanz,Gina LaRocca	2023	0
4	Heterologous high-level E. coli expression, purification and biophysical characterization of the spine-associated RapGAP (SPAR) PDZ domain Protein Expression and Purification ·Breann L. Brown,Michael S. Hadley,Rebecca Page	2008	8
5	Identification of a potent and selective 5-HT1B receptor antagonist Bioorganic & Medicinal Chemistry Letters ·Paul Wyman,Howard R. Marshall,Sean T. Flynn,Ron J. King,Mervyn Thompson,Paul W. Smith,Michael S. Hadley,Gary Price,Claire M. Scott,Lee A. Dawson	2005	2
6	The design of 8,8-Dimethyl[1,6]naphthyridines as potential anticonvulsant agents Bioorganic & Medicinal Chemistry Letters ·Nigel Austin,Michael S. Hadley,John D. Harling,Frank P. Harrington,Gregor J. Macdonald,Darren J. Mitchell,Graham J. Riley,Tania O. Stean,Geoffrey Stemp,Sharon C. Stratton,Mervyn Thompson,Neil Upton	2003	22
7	1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor Bioorganic & Medicinal Chemistry Letters ·Roderick A. Porter,Wai N. Chan,Steven Coulton,Amanda Johns,Michael S. Hadley,Katherine L. Widdowson,Jeffrey C. Jerman,Stephen Brough,Martyn C. Coldwell,Darren Smart,Frances Jewitt,Philip D. Jeffrey,Nigel Austin	2001	119
8	Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptor Bioorganic & Medicinal Chemistry Letters ·Nigel Austin,Kim Y. Avenell,Izzy Boyfield,Clive L. Branch,Michael S. Hadley,Philip D. Jeffrey,Christopher N. Johnson,Gregor J. Macdonald,David J. Nash,Graham J. Riley,Alexander B. Smith,Geoffrey Stemp,Kevin M. Thewlis,Antonio Vong,Martyn Wood	2001	13
9	Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptor Bioorganic & Medicinal Chemistry Letters ·Nigel Austin,Kim Y. Avenell,Izzy Boyfield,Clive L. Branch,Michael S. Hadley,Philip D. Jeffrey,Christopher N. Johnson,Gregor J. Macdonald,David J. Nash,Graham J. Riley,Alexander B. Smith,Geoffrey Stemp,Kevin M. Thewlis,Antonio Vong,Martyn Wood	2000	15
10	Evaluation of a Series of Anticonvulsant 1,2,3,4-Tetrahydroisoquinolinyl-benzamides Bioorganic & Medicinal Chemistry ·Wai N. Chan,Michael S. Hadley,John D. Harling,Hugh J. Herdon,Barry S. Orlek,Graham J. Riley,Rachel E.A. Stead,Tania O. Stean,Mervyn Thompson,Neil Upton,Robert W. Ward	2000	8
11	Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D3 receptor Bioorganic & Medicinal Chemistry Letters ·Kim Y. Avenell,Izzy Boyfield,Michael S. Hadley,Christopher N. Johnson,David J. Nash,Graham J. Riley,Geoffrey Stemp	1999	14
12	Identification of (−)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent Bioorganic & Medicinal Chemistry Letters ·Wai N. Chan,John Evans,Michael S. Hadley,Hugh J. Herdon,Jeffrey C. Jerman,Andrew A. Parsons,Simon Read,Tania O. Stean,Mervyn Thompson,Neil Upton	1999	46
13	Fused aminotetralins: novel antagonists with high selectivity for the dopamine D3 receptor Bioorganic & Medicinal Chemistry Letters ·Kim Y. Avenell,Izzy Boyfield,Martyn C. Coldwell,Michael S. Hadley,Maureen A.M. Healy,P.M. Jeffrey,Christopher N. Johnson,David J. Nash,Graham J. Riley,Emma E. Scott,Stephen A. Smith,Rachel Stacey,Geoffrey Stemp,Kevin M. Thewlis	1998	6
14	Identification of a series of 1,2,3,4-tetrahydroisoquinolinyl- benzamides with potential anticonvulsant activity Bioorganic & Medicinal Chemistry Letters ·Wai N. Chan,Michael S. Hadley,John D. Harling,Hugh J. Herdon,Jeffrey C. Jerman,Barry S. Orlek,Tania O. Stean,Mervyn Thompson,Neil Upton,Robert W. Ward	1998	12
15	Synthesis of Novel trans-4-(Substituted-benzamido)-3,4-dihydro-2H-benzo[b]pyran-3-ol Derivatives as Potential Anticonvulsant Agents with a Distinctive Binding Profile Journal of Medicinal Chemistry ·Wai N. Chan,John Evans,Michael S. Hadley,Hugh J. Herdon,Jeffrey C. Jerman,Helen K.A. Morgan,Tania O. Stean,Mervyn Thompson,Neil Upton,Antonio Vong	1996	22
16	Synthesis and antihypertensive activity of 3-[(substituted-carbonyl)amino]-2H-1-benzopyrans Journal of Medicinal Chemistry ·Frederick Cassidy,John Evans,Michael S. Hadley,Adele H. Haladij,Patricia E. Leach,Geoffrey Stemp	1992	61
17	Substituted benzamides with conformationally restricted side chains. 4. Hetero-azabicyclo[x.y.0] derivatives as gastric prokinetic agents. Bioorganic & Medicinal Chemistry Letters ·Michael S. Hadley,Frank D. King,Brian McRitchie,David H. Turner	1992	8
18	Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor Journal of Medicinal Chemistry ·Barry S. Orlek,Frank E. Blaney,Frank Brown,Michael Clark,Michael S. Hadley,John Hatcher,Graham J. Riley,Howard E. Rosenberg,Harry J. Wadsworth,Paul Wyman	1991	171
19	The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide Psychopharmacology ·Frank Brown,William Campbell,Michael Clark,Diane Graves,Michael S. Hadley,Joseph D. Hatcher,Philip B. Mitchell,P.L. Needham,Graham J. Riley,James Semple	1988	5
20	Substituted benzamides with conformationally restricted side chains. 2. Indolizidine derivatives as central dopamine receptor antagonists Journal of Medicinal Chemistry ·Frank D. King,Michael S. Hadley,Christine M. McClelland	1988	10

About Michael S. Hadley

Michael S. Hadley is a scholar working on Organic Chemistry, Physiology and Cellular and Molecular Neuroscience, having authored 55 papers that have together received 1.0k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (13 papers), Pharmacological Receptor Mechanisms and Effects (7 papers), Asymmetric Synthesis and Catalysis (7 papers), Synthesis of heterocyclic compounds (7 papers), Neuroscience and Neuropharmacology Research (6 papers), Cyclopropane Reaction Mechanisms (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Synthesis and Reactivity of Heterocycles (4 papers). The work is most often cited by research in Organic Chemistry (494 citations), Endocrine and Autonomic Systems (112 citations) and Cellular and Molecular Neuroscience (277 citations). Michael S. Hadley has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Graham J. Riley, Geoffrey Stemp, Michael Clark, Barry S. Orlek, John Evans, Frank D. King, Frank Brown, Paul Wyman, Nigel Austin and Wai N. Chan. Their work appears in journals such as Journal of Medicinal Chemistry, Psychopharmacology and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact